Innovative Therapeutic
Devices Addressing
Significant Unmet Needs
Latest News
AngelMD Closes Syndicate Funding Round in Fibralign
AngelMD,an investment and networking platform connecting innovative medical startups, physicians, investors, and industry partners, today announced that it has completed a Syndicate funding round for Fibralign, Inc. Fibralign produces therapeutic medical devices that...
Fibralign Corporation Appoints Dimitris Dionysiou, Ph.D., M.D. as Chief Medical Officer
Fibralign Corporation, a developer of advanced therapeutic medical devices, announces the appointment of Dimitris Dionysiou, Ph.D., M.D. as its Chief Medical Officer. Dr. Dionysiou joins the Company during the clinical phase for its first product, the BioBridge®...
Study shows nanofiber scaffolds could treat lymphedema by rerouting lymphatic system around blockage
Researchers at the School of Medicine have developed a possible treatment for lymphedema, the severe swelling of an arm or leg that can occur when the lymph system is blocked. Using scaffolding composed of specially patterned collagen nanofibers, the researchers...
* BioBridge has not been approved by the FDA for treating secondary lymphedema.
About Us
Fibralign is an award-winning, Stanford-spinout company that produces novel therapeutic biomedical devices that are designed to address major unmet medical needs.
The company has launched its first product, the BioBridge® Collagen Matrix, which has been developed to address secondary lymphedema*, a global chronic disease that currently has no cure.
BioBridge® Collagen Matrix
- Novel thread-like nanostructured surgical mesh for use in soft tissue repair
- Clinical benefit demonstrated in treating secondary lymphedema*
- CE mark approved, Class III device
- FDA 510(k) cleared device*
- Commercially available now in the US and Europe
Nanoweave® Technology
Fibralign is developing a pipeline of compelling novel products which are based on its proprietary Nanoweave® scaffolding platform that can be tailored to address a wide range of high-value applications. Nanoweave technology provides the means to precisely print 3D scaffolding in such a way that mimics human tissue nano structure and directly influence the body’s repair function.
Grants, Awards, Partners and Collaborators
Fibralign has been recognized for its vision and potential to impact lives globally. We are supported in our mission by world class partners and collaborators.
